Intrinsiqs

Is Spruce Biosciences, Inc. overvalued?

Spruce Biosciences, Inc. (SPRB) — key valuation metrics and fundamentals.

No verdict
Price
$43.31
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$124.5M
Dividend yield
0.0%
Return on equity
-118.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares SPRB's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.